Zypitamag Tablet, Film Coated
Product Images NDC 25208-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zypitamag (NDC 25208-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medicure International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (2bd9cad5 C46f 4e69 810e F8f7b8a79f4b 02)
This appears to be a table summarizing the results of several clinical trials comparing the effectiveness of different statin medications in reducing LDL cholesterol levels. The table includes the study ID numbers, the doses of each statin being compared, the adjusted mean percent change in LDL cholesterol levels, the 95% confidence interval, and the p-value for each comparison. The last row appears to indicate which medication was favored in each study.*
Image (2bd9cad5 C46f 4e69 810e F8f7b8a79f4b 05)
Zypitamag is a prescription drug containing 2.053 mg of pitavastatin magnesium equivalent to 2 mg of pitavastatin in each film-coated tablet. It is used as a cholesterol-lowering medication. Please see the package insert for dosage and full prescribing information. Zypitamag should be stored at room temperature, protected from moisture and light, in a child-resistant container. It is manufactured by Cadila Healthcare Ltd in Ahmedabad, India, and distributed by Medicure in Princeton, NJ, USA.*
Image (2bd9cad5 C46f 4e69 810e F8f7b8a79f4b 06)
This is a description for a medication called Zypitamag (Pitavastatin) tablets. Each film-coated tablet contains 2.053 mg of pitavastatin magnesium equivalent to 2 mg of pitavastatin. The usual dosage and directions for use should be obtained from the package insert. These tablets should be stored at 20°C to 25°C (68°F to 77°F), and kept out of reach of children. The tablets can be removed from the packaging by pushing them through the foi seal from the front. The medication is distributed by Medicure in Princeton, NJ and manufactured by Cadila Healthcare Ltd in Ahmedabad, India. This medication is not child-resistant, and should not be used in households with young children. This package is a professional sample and not for sale.*
Image (2bd9cad5 C46f 4e69 810e F8f7b8a79f4b 07)
Each tablet of Zypltamag contains 4mg of pitavastatin magnesium. The package is child-resistant and should be stored at 20°C to 25°C, protected from moisture and light. The tablets should be kept in an appropriate container and out of the reach of children. The medication is manufactured by Cadia Healthcare Ltd and distributed by Medicure in the USA. Recommended dosage instructions can be found in the package insert for full prescribing information.*
Image (2bd9cad5 C46f 4e69 810e F8f7b8a79f4b 08)
This is a medication package for Zypitamag tablets containing 4mg of pitavastatin, manufactured by Cadila Healthcare Ltd in India and distributed by Medicure in New Jersey. The tablets are film-coated and each tablet contains 4.106mg of pitavastatin magnesium. The usual dosage should be taken as directed by a physician, and for further information, one should refer to the package insert. This package is not child-resistant and should be kept out of the reach of children. It is only for professional use, contains 7 tablets and the NDC number is 25208-202-10.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.